We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
+4.87%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$106B
AUM Growth
+$3.62B
(+3.5%)
Cap. Flow
-$1.47B
Cap. Flow
% of AUM
-1.39%
Top 10 Holdings %
Top 10 Hldgs %
14.33%
Holding
3,812
New
177
Increased
783
Reduced
2,146
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$743M |
| 2 |
APC
Anadarko Petroleum
APC
|
+$215M |
| 3 |
Chevron
CVX
|
+$189M |
| 4 |
XEC
CIMAREX ENERGY CO
XEC
|
+$161M |
| 5 |
Meta Platforms (Facebook)
META
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$281M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$219M |
| 4 |
Eli Lilly
LLY
|
+$212M |
| 5 |
RTX Corp
RTX
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.44% |
| 2 | Healthcare | 15.11% |
| 3 | Industrials | 11.28% |
| 4 | Energy | 10.95% |
| 5 | Technology | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GIMO
2626
DELISTED
Gigamon Inc.
GIMO
| $197K | ﹤0.01% |
10,309
+6,188
| +150% | +$112K |
|
|
IMMU
2627
DELISTED
Immunomedics Inc
IMMU
| $196K | ﹤0.01% |
53,777
-1,608
| -3% | -$5.9K |
|
|
CHDX
2628
DELISTED
CHINDEX INTL INC
CHDX
| $195K | ﹤0.01% |
8,230
-801
| -9% | -$18.5K |
|
2629
Univest Financial
UVSP
$1.23B
| $194K | ﹤0.01% |
9,355
-1,774
| -16% | -$35.4K |
|
|
ATRS
2630
DELISTED
Antares Pharma, Inc.
ATRS
| $194K | ﹤0.01% |
72,618
-8,638
| -11% | -$26K |
|
|
METR
2631
DELISTED
METRO BANCORP, INC COMMON STOCK
METR
| $194K | ﹤0.01% |
8,407
-1,368
| -14% | -$29.2K |
|
2632
CEVA Inc
CEVA
$1.01B
| $191K | ﹤0.01% |
12,929
-2,616
| -17% | -$40.9K |
|
2633
Consolidated Edison
ED
$41.6B
| $191K | ﹤0.01% |
3,316
-53
| -2% | -$2.96K |
|
|
FLIC
2634
DELISTED
First of Long Island Corp
FLIC
| $191K | ﹤0.01% |
10,994
-1,770
| -14% | -$30.1K |
|
|
K
2635
DELISTED
Kellanova
K
| $191K | ﹤0.01% |
3,100
-50
| -2% | -$3.13K |
|
|
PGNX
2636
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $191K | ﹤0.01% |
44,228
-6,711
| -13% | -$25.6K |
|
|
PSTB
2637
DELISTED
Park Sterling Corp.
PSTB
| $191K | ﹤0.01% |
29,055
-4,271
| -13% | -$28.1K |
|
|
OSIR
2638
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $191K | ﹤0.01% |
12,245
-1,058
| -8% | -$15.6K |
|
2639
Ingles Markets
IMKTA
$1.63B
| $190K | ﹤0.01% |
7,196
-669
| -9% | -$17.1K |
|
|
FNHC
2640
DELISTED
FedNat Holding Company Common Stock
FNHC
| $190K | ﹤0.01% |
7,448
+4,717
| +173% | +$103K |
|
|
INWK
2641
DELISTED
InnerWorkings, Inc.
INWK
| $190K | ﹤0.01% |
22,320
-6,141
| -22% | -$45.9K |
|
|
CBK
2642
DELISTED
Christopher & Banks Corporation
CBK
| $190K | ﹤0.01% |
21,649
-6,751
| -24% | -$46.7K |
|
2643
Alto Ingredients
ALTO
$360M
| $189K | ﹤0.01% |
12,334
+9,110
| +283% | +$126K |
|
2644
Banc of California
BANC
$3.28B
| $189K | ﹤0.01% |
17,378
+4,382
| +34% | +$50K |
|
2645
Financial Institutions
FISI
$800M
| $189K | ﹤0.01% |
8,059
-1,369
| -15% | -$32K |
|
2646
TherapeuticsMD
TXMD
$23.8M
| $189K | ﹤0.01% |
853
-47
| -5% | -$10.5K |
|
|
DTSI
2647
DELISTED
DTS, Inc.
DTSI
| $189K | ﹤0.01% |
10,281
-1,779
| -15% | -$32.5K |
|
2648
Cerus
CERS
$587M
| $188K | ﹤0.01% |
45,358
-4,114
| -8% | -$17.6K |
|
2649
Kodak
KODK
$806M
| $188K | ﹤0.01% |
+7,665
| New | +$219K |
|
|
TXTR
2650
DELISTED
TEXTURA CORPORATION COM
TXTR
| $188K | ﹤0.01% |
7,932
+5,083
| +178% | +$103K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, BlackRock Advisors held 3,812 positions worth $106B, up 3.5% from $102B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock Advisors's Q2 2014 filing shows 177 new, 783 increased, 2,146 reduced and 145 closed positions. Its largest new stake was iShares US Financials ETF: 3,120,594 shares worth $130M. The largest sale was Pfizer, an estimated $281M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.
- BlackRock Advisors's largest Q2 2014 buy was iShares US Financials ETF: 3,120,594 shares worth $130M.
- BlackRock Advisors added most to Apple in Q2 2014, an estimated $743M increase.
- BlackRock Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $281M.
- BlackRock Advisors fully exited PPL CORP CORP UITS CONSISTING OF PUR CONTRACT JR SUB NTS in Q2 2014, selling an estimated $40.9M.
- BlackRock Advisors's ten largest holdings make up 14% of its $106B portfolio in Q2 2014.
- BlackRock Advisors opened 177 new positions and closed 145 in Q2 2014.
- BlackRock Advisors's portfolio value rose 3.5% quarter-over-quarter to $106B.
Based on BlackRock Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.